International Prevention Research Institute - Collaborating Centre, Calisia University, 16 Kaszubska St., 62-800 Kalisz, Poland; Department of Gynecologic Oncology and Obstetrics, Centre of Postgraduate Medical Education, 231 Czerniakowska St., 00-416 Warsaw, Poland.
Department of Biomedical and Clinical Sciences, Università Degli Studi di Milano, Via Giovanni Battista Grassi 74, 20157 Milan, Italy.
Eur J Cancer. 2021 Jul;152:4-17. doi: 10.1016/j.ejca.2021.04.026. Epub 2021 May 29.
Breast cancer mortality in European women has been falling for three decades. We analysed trends in mortality from breast cancer in Europe over the period 1980-2017 and predicted number of deaths and rates to 2025.
We extracted death certification data for breast cancer in women for 35 European countries, between 1980 and 2017, from the World Health Organisation database. We computed the age-standardised (world standard population) mortality rates per 100,000 person-years, by country and calendar year. We obtained also predictions for 2025 using a joinpoint regression model and calculated the number of avoided deaths over the period 1994-2025.
The mortality rate declined from 15.0 in 2012 to 14.4 in 2017 per 100,000 women (-3.9%) for the European Union (EU)-27. This fall was greater in the EU-14 (-5.2%), whereas rates rose in the transitional countries during this period by 1.9%. Mortality rate predictions across Europe are expected to reach relatively uniform levels in 2025. During the studied period, favourable trends in mortality emerged in most countries, with the greatest decrease in Denmark, whereas Poland and Romania showed an upward trend. The largest predicted decrease in breast cancer mortality was estimated for the United Kingdom (12.2/100,000 women in 2025), leading to the estimated avoidance of 150,000 breast cancer deaths over the period 1994-2025 and 470,000 in the EU-27.
Favourable trends in breast cancer mortality were observed in most European countries, and they will continue to fall in the coming years. Less favourable patterns were still observed among the transitional countries than other European areas.
欧洲女性的乳腺癌死亡率已经下降了三十年。我们分析了 1980 年至 2017 年期间欧洲乳腺癌死亡率的趋势,并预测了 2025 年的死亡人数和死亡率。
我们从世界卫生组织数据库中提取了 1980 年至 2017 年期间 35 个欧洲国家女性乳腺癌的死亡证明数据。我们按国家和日历年度计算了每 10 万人年的标准化(世界标准人口)死亡率。我们还使用连接点回归模型获得了 2025 年的预测值,并计算了 1994 年至 2025 年期间避免的死亡人数。
欧盟 27 国的死亡率从 2012 年的每 10 万人 15.0 例下降到 2017 年的 14.4 例(下降 3.9%)。欧盟 14 国(下降 5.2%)的降幅更大,而在此期间转型期国家的死亡率上升了 1.9%。预计到 2025 年,欧洲各地的死亡率预测值将达到相对统一的水平。在研究期间,大多数国家的死亡率趋势都有所改善,丹麦的降幅最大,而波兰和罗马尼亚则呈上升趋势。英国预计乳腺癌死亡率下降幅度最大(2025 年每 10 万人 12.2 例),预计在 1994 年至 2025 年期间将避免 15 万例乳腺癌死亡,在欧盟 27 国将避免 47 万例乳腺癌死亡。
大多数欧洲国家的乳腺癌死亡率呈有利趋势,未来几年还将继续下降。转型期国家的情况仍不如其他欧洲地区有利。